Literature DB >> 11076093

The immunosuppressive cytokines influence the fetal survival in patients with pregnancy-induced hypertension.

V Del Gobbo1, M G Giganti, R Zenobi, V Villani, M G Premrov.   

Abstract

PROBLEM: The present study examines the hypothesis that the elevated levels of transforming growth factor (TGF)-beta1 and interleukin (IL)-10 would be protective for the fetus survival during pregnancy-induced hypertension (PIH). Moreover, we evaluate the IL-12 and IL-15 serum concentrations and their relationships with PIH. METHOD OF STUDY: Serum samples were obtained before the onset of labor from control and PIH groups. Cytokine concentrations were determined by Enzyme-Linked Immunoadsorbent Assay.
RESULTS: Our data show that PIH women have significantly higher TGF-beta1 and IL-10 concentrations with respect to control groups (P = 0.0001). Similarly, macrophages from the PIH placentas produce in vitro more elevated TGF-beta1 and IL-10 levels compared to normal pregnant ones (P = 0.02), also in the absence of LPS stimulation. IL-12 and IL-15 serum concentrations were not detectable in all pregnant groups.
CONCLUSION: We have found that PIH women have elevated concentrations of anti-inflammatory/immunosuppressive cytokines, suggesting their important role in fetal allograft protection during the normal and pathological pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076093     DOI: 10.1111/j.8755-8920.2000.440405.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

1.  Expression of TGF-betal in placenta of the patients with pregnancy-induced hypertension and its relationship with serum VCAM-1.

Authors:  Wenpei Xiang; Xiaoyan Xu; Hanping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 2.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.